Preview

Сибирский научный медицинский журнал

Advanced search

Algorithm for determining the authenticity of biomedical cell preparations containing mesenchymal stem cells

https://doi.org/10.18699/SSMJ20230109

Abstract

The use of mesenchymal stem cells (MSCs), which have a pronounced immunomodulatory activity, is a promising direction in the development of biomedical cell preparations (BMCPs). In oncohematology, the use of BMCPs containing MSCs is aimed at supporting hematopoiesis during cotransplantation with hematopoietic stem cells (HSCs) and suppressing immune conflicts during allogeneic unrelated transplantation and severe autoimmune processes. An obligatory stage of registration of BMCPs is confirmation of the identity of the MSC cell line (CL), which includes the establishment of morphological characteristics, evaluation of the expression of specific markers and proteins, and confirmation of the genetic stability of CL during cultivation. Determination of markers of genetic stability is possible using various methods, however, according to the recommendations of the American National Standardization Institute, the standard is the analysis of short tandem repeats (STR analysis). The purpose of the study is to develop an algorithm for determining the authenticity of BMCPs containing MSCs, including STR analysis. Material and methods. Identification of MSC cells in BMCP was performed according to the criteria of the International Society for Cell Therapy. Viable cells were counted in a Goryaev chamber. Immunophenotypic characteristics of MSCs were determined by flow cytometry. The level of production of specific proteins was assessed using enzyme immunoassay. Genetic stability markers were identified by STR analysis. Results and discussion. The methods were tested in triplicate for ten BMCP samples to confirm the reproducibility and reliability of the results. The developed algorithm for determining the authenticity of BMCP has a high accuracy, as it includes the STR analysis technique, which makes it possible to identify 19 polymorphic STR markers located on different alleles. Using the method will allow BMCP manufacturers to go through the procedure of state registration of drugs.

About the Authors

S. S. Druzhinina
Kirov Research Institute of Hematology and Blood Transfusion of FMBA of Russia
Russian Federation

Svetlana S. Druzhinina

610027, Kirov, Krasnoarmeyskaya str., 72



M. A. Loginova
Kirov Research Institute of Hematology and Blood Transfusion of FMBA of Russia; Vyatka State University
Russian Federation

Maria A. Loginova, doctor of biological sciences

610027, Kirov, Krasnoarmeyskaya str., 72;

610000, Kirov, Moskovskaya str., 36



D. N. Smirnova
Kirov Research Institute of Hematology and Blood Transfusion of FMBA of Russia
Russian Federation

Daria N. Smirnova, candidate of biological sciences

610027, Kirov, Krasnoarmeyskaya str., 72



I. P. Obukhov
Kirov Research Institute of Hematology and Blood Transfusion of FMBA of Russia
Russian Federation

Ivan P. Obukhov

610027, Kirov, Krasnoarmeyskaya str., 72



K. O. Yaroshenko
Kirov Research Institute of Hematology and Blood Transfusion of FMBA of Russia
Russian Federation

Kristina O. Yaroshenko

610027, Kirov, Krasnoarmeyskaya str., 72



E. A. Poponina
Kirov Research Institute of Hematology and Blood Transfusion of FMBA of Russia
Russian Federation

Elena A. Poponina, candidate of medical sciences

610027, Kirov, Krasnoarmeyskaya str., 72



E. L. Nazarova
Kirov Research Institute of Hematology and Blood Transfusion of FMBA of Russia
Russian Federation

Elena L. Nazarova, candidate of medical sciences

610027, Kirov, Krasnoarmeyskaya str., 72



N. V. Isaeva
Kirov Research Institute of Hematology and Blood Transfusion of FMBA of Russia
Russian Federation

Natalya V. Isaeva, candidate of biological sciences

610027, Kirov, Krasnoarmeyskaya str., 72



I. V. Paramonov
Kirov Research Institute of Hematology and Blood Transfusion of FMBA of Russia
Russian Federation

Igor V. Paramonov, doctor of medical sciences

610027, Kirov, Krasnoarmeyskaya str., 72



References

1. Zvonkov E.E., Koroleva D.A., Gabeeva N.G., Gavrilina O.A., Fedorova S.Yu., Gubkin A.V., Kovrigina A.M., Yatsyk G.A., Klyasova G.A., Savenko T.A., Savchenko V.G. High-dose chemotherapy for primary diffuse large β-cell lymphoma of the central nervous system. interim results of the CNS-2015 protocol. Gematologiya i transfuziologiya = Hematology and Transfusiology. 2019;64(4): 447–461. [In Russian]. doi: 10.35754/0234-5730-2019-64-4-447-461

2. Graft-versus-host reaction. [In Russian]. Available at: https://www.podari-zhizn.ru/main/node/7769 (date of access: 05/06/2022).

3. Order of Minzdrav of Russia dated January 19, 2017 Nо 14n “On approval of the specification form for a biomedical cell product”. [In Russian]. Available at: http://www.consultant.ru/document/cons_doc_LAW_212714/

4. Melnikova E.V., Rachinskaya O.A., Trusov G.A., Khorolsky M.D., Semenova I.S., Tereshkina N.V., Merkulov V.A. Justification of methodological approaches to identification testing of biomedical cell products. BIOpreparaty. Profilaktika, diagnostika, lecheniye = BIOpreparations. Prevention, Diagnosis, Treatment. 2019;19(1):28–38. [In Russian]. doi: 10.30895/2221-996X-2019-19-1-28-38

5. SME Workshop on CMC of Biological Medicinal Products. EMA London. CMC ISSUES for Cell Based ATMP. Available at: https://www.ema.europa.eu/en/documents/presentation/presentation-sme-workshopcmc-biological-medicinal-products-margaridamenezes-ferreira_en.pdf

6. Q5D Quality of Biotechnological/Biological Products: Derivation and Characterization of Cell Substrates Used for Production of Biotechnological/ Biological Products. Available at: https://www.fda.gov/regulatory-information/search-fda-guidancedocuments/q5d-quality-biotechnologicalbiologicalproducts-derivation-and-characterization-cellsubstrates-used

7. Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks (WHO/BS/10.2132). Available at: https://gxpacademy.org/upload/iblock/8df/8df32e5342a440d38ed3e5b0fbec42ca.pdf

8. Single nucleotide polymorphisms in forensic genetics: SNP detection methods. [In Russian]. Available at: https://testgen.ru/ru/nauchnyie-issledovaniya/stati-i-spravochnye-materialy/odnonukleotidnye-polimorfizmy-v-sudebnoy-genetike-metody-detektsii-snp/ [In Russian].

9. SME Workshop on CMC of Biological Medicinal Products. EMA London 14–16.04.2015. CMC ISSUES for Cell Based ATMP. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Presentation/2015/05/WC500187353.pdf

10. American Type Culture Collection Standards Development Organization Workgroup ASN-0002. Cell line misidentification: the beginning of the end. Nat. Rev. Cancer. 2010;10(6):441–448. doi: 10.1038/nrc2852/


Review

For citations:


Druzhinina S.S., Loginova M.A., Smirnova D.N., Obukhov I.P., Yaroshenko K.O., Poponina E.A., Nazarova E.L., Isaeva N.V., Paramonov I.V. Algorithm for determining the authenticity of biomedical cell preparations containing mesenchymal stem cells. Сибирский научный медицинский журнал. 2023;43(1):88-95. (In Russ.) https://doi.org/10.18699/SSMJ20230109

Views: 361


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2410-2512 (Print)
ISSN 2410-2520 (Online)